ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis - PubMed (original) (raw)

Review

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis

A C Simões e Silva et al. Br J Pharmacol. 2013 Jun.

Abstract

Recent advances have improved our understanding of the renin-angiotensin system (RAS). These have included the recognition that angiotensin (Ang)-(1-7) is a biologically active product of the RAS cascade. The identification of the ACE homologue ACE2, which forms Ang-(1-7) from Ang II, and the GPCR Mas as an Ang-(1-7) receptor have provided the necessary biochemical and molecular background and tools to study the biological significance of Ang-(1-7). Most available evidence supports a counter-regulatory role for Ang-(1-7) by opposing many actions of Ang II on AT₁ receptors, especially vasoconstriction and proliferation. Many studies have now shown that Ang-(1-7) by acting via Mas receptor exerts inhibitory effects on inflammation and on vascular and cellular growth mechanisms. Ang-(1-7) has also been shown to reduce key signalling pathways and molecules thought to be relevant for fibrogenesis. Here, we review recent findings related to the function of the ACE2/Ang-(1-7)/Mas axis and focus on the role of this axis in modifying processes associated with acute and chronic inflammation, including leukocyte influx, fibrogenesis and proliferation of certain cell types. More attention will be given to the involvement of the ACE2/Ang-(1-7)/Mas axis in the context of renal disease because of the known relevance of the RAS for the function of this organ and for the regulation of kidney inflammation and fibrosis. Taken together, this knowledge may help in paving the way for the development of novel treatments for chronic inflammatory and renal diseases.

© 2013 The Authors. British Journal of Pharmacology © 2013 The British Pharmacological Society.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Schematic representation for the role of ACE2-Ang-(1-7)-Mas receptor axis on renal tissue.

Figure 2

Figure 2

Schematic representation of the RAS effects on inflammatory cells. Main components of the RAS are present on macrophages (A), lymphocytes (B), dendritic cells (C) and neutrophils (D) and modulate inflammatory response by affecting cytokine production and release, cellular migration and signalling pathways.

Similar articles

Cited by

References

    1. Agarwal D, Elks CM, Reed SD, Mariappan N, Majid DS, Francis J. Chronic exercise preserves renal structure and hemodynamics in spontaneously hypertensive rats. Antioxid Redox Signal. 2012;16:139–152. - PMC - PubMed
    1. Allred AJ, Chappell MC, Ferrario CM, Diz DI. Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol Renal Physiol. 2000;279:F636–F645. - PubMed
    1. Alvarez A, Piqueras L, Bello R, Canet A, Moreno L, Kubes P, et al. Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivo. Br J Pharmacol. 2001;132:677–684. - PMC - PubMed
    1. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci. 2003;116(Pt 2):217–224. - PubMed
    1. Azizi M, Menard J. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation. 2004;109:2492–2499. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources